AI assistant
Sending…
ADMA BIOLOGICS, INC. — Director's Dealing 2015
Dec 3, 2015
31261_dirs_2015-12-03_a6debad2-ed69-456d-9e41-28dbdc61e90f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ADMA BIOLOGICS, INC. (ADMA)
CIK: 0001368514
Period of Report: 2015-12-02
Reporting Person: LENZ BRIAN (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-02 | Common Stock, $0.0001 par value per share | P | 250 | $9.181 | Acquired | 5250 | Direct |
| 2015-12-02 | Common Stock, $0.0001 par value per share | P | 250 | $9.1521 | Acquired | 5500 | Direct |
| 2015-12-02 | Common Stock, $0.0001 par value per share | P | 500 | $9.135 | Acquired | 6000 | Direct |
More from ADMA BIOLOGICS, INC.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 15
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Mar 2